US FDA Authorises First Oral Antiviral For Treatment Of COVID

The US Food and Drug Administration has granted Pfizer's Paxlovid an emergency use authorization for the treatment of COVID-19 in adults and children (12 years of age and older). "Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally, a major step forward in fighting COVID-19," the FDA added.